Novel use of a peptide class of compound for treating non neuropathic inflammatory pain

Details for Australian Patent Application No. 2002257681 (hide)

International Classifications

Event Publications

27 March 2003 Application Open to Public Inspection

Published as AU-B-2002257681

4 March 2004 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 02 Feb 2004

7 June 2007 Application Accepted

Published as AU-B-2002257681

4 October 2007 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 10 Sep 2007. Address for service in Australia - Griffith Hack Level 3 509 St Kilda Road Melbourne VIC 3004

11 October 2007 Standard Patent Sealed

21 February 2008 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 10 Sep 2007

10 June 2010 Alteration of Name

The name of the patentee has been altered to UCB Pharma GmbH

18 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.